| 前收盘价格 | 833.16 |
| 收盘价格 | 832.15 |
| 成交量 | 197,028 |
| 平均成交量 (3个月) | 358,860 |
| 市值 | 51,644,796,928 |
| 市盈率 (P/E TTM) | 35.71 |
| 预期市盈率 (P/E Forward) | 27.47 |
| 价格/销量 (P/S) | 14.83 |
| 股市价格/股市净资产 (P/B) | 8.24 |
| 52周波幅 | |
| 利润日期 | 30 Oct 2025 |
| 营业毛利率 | 40.26% |
| 营业利益率 (TTM) | 17.50% |
| 稀释每股收益 (EPS TTM) | 16.39 |
| 季度收入增长率 (YOY) | 95.70% |
| 总债务/股东权益 (D/E MRQ) | 0.71% |
| 流动比率 (MRQ) | 7.29 |
| 营业现金流 (OCF TTM) | -82.75 M |
| 杠杆自由现金流 (LFCF TTM) | -143.39 M |
| 资产报酬率 (ROA TTM) | -0.21% |
| 股东权益报酬率 (ROE TTM) | 17.36% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | argenx SE | 看涨 | 看涨 |
AIStockmoo 评分
1.5
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.5 |
| 平均 | 1.50 |
|
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Mid Growth |
| 机构持股比例 | 55.54% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 1,317.00 (Wells Fargo, 57.81%) | 购买 |
| 中 | 1,091.00 (30.73%) | |
| 低 | 858.00 (Baird, 2.81%) | 保留 |
| 平均值 | 1,075.44 (28.87%) | |
| 总计 | 8 购买, 1 保留 | |
| 平均价格@调整类型 | 846.16 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wells Fargo | 20 Jan 2026 | 1,317.00 (57.81%) | 购买 | 809.64 |
| 16 Dec 2025 | 1,264.00 (51.46%) | 购买 | 851.42 | |
| Wedbush | 14 Jan 2026 | 1,000.00 (19.83%) | 购买 | 799.33 |
| 14 Nov 2025 | 1,000.00 (19.83%) | 购买 | 907.98 | |
| Citigroup | 08 Jan 2026 | 1,091.00 (30.73%) | 购买 | 795.57 |
| 17 Nov 2025 | 1,124.00 (34.68%) | 购买 | 929.61 | |
| Truist Securities | 08 Jan 2026 | 1,030.00 (23.42%) | 购买 | 795.57 |
| Baird | 18 Dec 2025 | 858.00 (2.81%) | 保留 | 847.05 |
| RBC Capital | 17 Dec 2025 | 925.00 (10.84%) | 购买 | 862.05 |
| Stifel | 11 Dec 2025 | 1,248.00 (49.54%) | 购买 | 889.49 |
| JP Morgan | 08 Dec 2025 | 1,100.00 (31.81%) | 购买 | 900.76 |
| Morgan Stanley | 04 Dec 2025 | 1,110.00 (33.01%) | 购买 | 915.97 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合